ArticlePharmacology research & perspectives2023

Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti-seizure medication: Levetiracetam case study.

Annie Delaunois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.